1. The process for preventing tachyphylaxis of amphetamine administered to a patient which comprises administering to said patient concomitantly with said amphetamine a catecholamine precursor selected from the group consisting of tyrosine, a tyrosine precursor or a mixture of tyrosine and a tyrosine precursor to obtain a tyrosine blood plasma concentration between about 15 and 100 .mu.g/ml.